AXSM — AXSOME THERAPEUTICS INC

Ownership history in Nicholas Investment Partners, LP  ·  18 quarters on record

This page tracks every 13F SEC filing in which Nicholas Investment Partners, LP reported a position in AXSOME THERAPEUTICS INC (AXSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.06% (2023 Q3)
Avg. % of fund
0.85%
First filed
2019 Q4
Last filed
2025 Q4
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 91,564 +42,907 +88.2% 1.22% $16.7M $182.64
2025 Q3 ADDED 48,657 +6,503 +15.4% 0.45% $5.9M $121.45
2025 Q2 REDUCED 42,154 -1,418 -3.3% 0.39% $4.4M $104.39
2025 Q1 ADDED 43,572 +33,437 +329.9% 0.52% $5.1M $116.63
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AXSM price (monthly, adj. close)

Other funds also holding AXSM

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 59.3% IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 4.96% Tri Locum Partners LP 3Y 4.78% PFM Health Sciences, LP 3Y 7Y 4.58% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.52% First Turn Management, LLC 4.32% Deep Track Capital, LP 3Y 3.74% SUPERSTRING CAPITAL MANAGEMENT LP 3.66% Rhenman & Partners Asset Management AB 3Y 7Y 1.96% Privium Fund Management B.V. 3Y 1.91%
← Back to Nicholas Investment Partners, LP Holdings